Need for the iBreast trial – risk adjusted breast cancer follow-up trial
Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Need for the iBreast trial – risk adjusted breast cancer follow-up trial. BMJ . ISSN 0959-535XFull text not available from this repository.
Official URL: http://www.bmj.com/
Whilst we appreciate that Dixon’s reviews on breast cancer follow-up are evidence-based, we are concerned that neither his recommendations for discharge 2 years post-treatment (1) nor the current NICE guidelines for discharge before 3 years (2) are based on randomised evidence; a concern previously shared by others (3).
|Item Type:||Journal Item|
|Subjects:||R Medicine > R Medicine (General)|
|Divisions:||Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
|Journal or Publication Title:||BMJ|
|Publisher:||BMJ Publishing Group Ltd.|
|Official Date:||12 March 2008|
|Access rights to Published version:||Restricted or Subscription Access|
Actions (login required)